Optimizing Small Molecule Formulation to Ensure Degradable Implant Safety
Time: 11:15 am
day: Day One
Details:
- Re-evaluating formulation to minimize clinical stage adverse side effects
- Designing implant size and shape to optimize performance
- Overcoming regulatory barriers to achieve multiple injection approval
